Skotnicki A - Search Results

1

Immunoregulatory actions of calf thymus extract (TFX®) in vitro in relation to its effect on expression of mitogen activated protein kinases.

Zimecki M, Kochanowska I, Zaczyńska E, Kocięba M, Artym J, Zambrowicz A, Matwiejczyk M, Besman M, Kuchar K, Skotnicki A. Zimecki M, et al. Among authors: skotnicki a. Int Immunopharmacol. 2023 May;118:109995. doi: 10.1016/j.intimp.2023.109995. Epub 2023 Mar 23. Int Immunopharmacol. 2023. PMID: 36963263

2

Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies.

Topp M, Dlugosz-Danecka M, Skotnicki AB, Salogub G, Viardot A, Klein AK, Hess G, Michel CS, Grosicki S, Gural A, Schwarz SE, Pietzko K, Gärtner U, Strassz A, Alland L, Mayer J. Topp M, et al. Among authors: skotnicki ab. Trials. 2023 Jan 3;24(1):4. doi: 10.1186/s13063-022-06982-7. Trials. 2023. PMID: 36597128 Free PMC article. Clinical Trial.

3

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study.

Gisslinger H, Klade C, Georgiev P, Krochmalczyk D, Gercheva-Kyuchukova L, Egyed M, Rossiev V, Dulicek P, Illes A, Pylypenko H, Sivcheva L, Mayer J, Yablokova V, Krejcy K, Grohmann-Izay B, Hasselbalch HC, Kralovics R, Kiladjian JJ; PROUD-PV Study Group. Gisslinger H, et al. Lancet Haematol. 2020 Mar;7(3):e196-e208. doi: 10.1016/S2352-3026(19)30236-4. Epub 2020 Jan 31. Lancet Haematol. 2020. PMID: 32014125 Clinical Trial.

4

Consolidation with ⁹⁰Y ibritumomab tiuxetan radioimmunotherapy in mantle cell lymphoma patients ineligible for high dose therapy: results of the phase II multicentre Polish Lymphoma Research Group trial, after 8-year long follow-up.

Jurczak W, Gruszka AM, Sowa Staszczak A, Dlugosz-Danecka M, Szostek M, Zimowska-Curylo D, Giza A, Krawczyk K, Jakobczyk M, Hubalewska-Dydejczyk A, Szymczyk M, Wróbel T, Knopińska-Posłuszny W, Kisiel E, Skotnicki A, Zinzani PL. Jurczak W, et al. Among authors: skotnicki a. Leuk Lymphoma. 2019 Nov;60(11):2689-2696. doi: 10.1080/10428194.2019.1602261. Epub 2019 Apr 9. Leuk Lymphoma. 2019. PMID: 30961415 Clinical Trial.

5

The average relative dose intensity of R-CHOP is an independent factor determining favorable overall survival in diffuse large B-cell lymphoma patients.

Długosz-Danecka M, Szmit S, Ogórka T, Skotnicki AB, Jurczak W. Długosz-Danecka M, et al. Among authors: skotnicki ab. Cancer Med. 2019 Mar;8(3):1103-1109. doi: 10.1002/cam4.2008. Epub 2019 Feb 10. Cancer Med. 2019. PMID: 30740919 Free PMC article.

6

Primary Cardioprotection Reduces Mortality in Lymphoma Patients with Increased Risk of Anthracycline Cardiotoxicity, Treated by R-CHOP Regimen.

Długosz-Danecka M, Gruszka AM, Szmit S, Olszanecka A, Ogórka T, Sobociński M, Jaroszyński A, Krawczyk K, Skotnicki AB, Jurczak W. Długosz-Danecka M, et al. Among authors: skotnicki ab. Chemotherapy. 2018;63(4):238-245. doi: 10.1159/000492942. Epub 2018 Oct 29. Chemotherapy. 2018. PMID: 30372698

7

Rituximab, cladribine, and cyclophosphamide (RCC) induction with rituximab maintenance in chronic lymphocytic leukemia: PALG - CLL4 (ML21283) trial.

Robak T, Błoński J, Skotnicki AB, Piotrowska M, Wróbel T, Rybka J, Kłoczko J, Bołkun Ł, Budziszewska BK, Walczak U, Uss A, Fidecka M, Smolewski P. Robak T, et al. Among authors: skotnicki ab. Eur J Haematol. 2018 May;100(5):465-474. doi: 10.1111/ejh.13042. Epub 2018 Mar 22. Eur J Haematol. 2018. PMID: 29427355 Clinical Trial.

8

Ferritinemia and serum inflammatory cytokines in Swedish adults with Gaucher disease type 1.

Lorenz F, Pawłowicz E, Klimkowska M, Beshara S, Bulanda Brustad A, Skotnicki AB, Wahlin A, Machaczka M. Lorenz F, et al. Among authors: skotnicki ab. Blood Cells Mol Dis. 2018 Feb;68:35-42. doi: 10.1016/j.bcmd.2016.10.010. Epub 2016 Oct 20. Blood Cells Mol Dis. 2018. PMID: 27816428

9

Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A.

Mahlangu J, Kuliczkowski K, Karim FA, Stasyshyn O, Kosinova MV, Lepatan LM, Skotnicki A, Boggio LN, Klamroth R, Oldenburg J, Hellmann A, Santagostino E, Baker RI, Fischer K, Gill JC, P'Ng S, Chowdary P, Escobar MA, Khayat CD, Rusen L, Bensen-Kennedy D, Blackman N, Limsakun T, Veldman A, St Ledger K, Pabinger I; AFFINITY Investigators. Mahlangu J, et al. Among authors: skotnicki a. Blood. 2016 Aug 4;128(5):630-7. doi: 10.1182/blood-2016-01-687434. Epub 2016 Jun 21. Blood. 2016. PMID: 27330001 Free PMC article. Clinical Trial.

10

Single-agent MOR208 salvage and maintenance therapy in a patient with refractory/relapsing diffuse large B-cell lymphoma: a case report.

Jurczak W, Bryk AH, Mensah P, Gałązka K, Trofimiuk-Müldner M, Wyrobek Ł, Sawiec A, Skotnicki AB. Jurczak W, et al. Among authors: skotnicki ab. J Med Case Rep. 2016 May 14;10(1):123. doi: 10.1186/s13256-016-0875-x. J Med Case Rep. 2016. PMID: 27178351 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

287 results

Search Page